Neurotronics becomes a subsidiary of Nihon Kohden on December 31, 2008. Nihon Kohden is expected to strengthen its position as a leader in the neurology business with the acquisition of Neurotronics.
Through the combined efforts of both companies, Nihon Kohden expects to increase world-wide sales in sleep and set a foundation for its long-term strategy in the sleep and neurodiagnostic fields, with the continuing goal of improving the quality of medical treatment.
Fumio Suzuki, president and COO of Nihon Kohden, said: “Nihon Kohden and Neurotronics have been long-standing strategic partners in the sleep-respiratory business.
“Through this acquisition, we can synergize Nihon Kohden’s neurology diagnostics technology and Neurotronics’s sleep analysis expertise to strengthen our products and services in this growing sleep-respiratory market. We also expect to increase both companies’ sales by leveraging Nihon Kohden’s global distribution network.”